|
PORTFOLIO COMPANIES
|
HealthpointCapital is a values-driven, research-based private equity firm
exclusively focused on the musculoskeletal sector — specifically orthopedics and dental. HealthpointCapital manages in excess of $750 million of institutional capital.
Orthopedic & Dental Industry Research
Most Recent Blog Articles Complete Archive »
Align, Biomet, Dentsply and Zimmer report dental sales . . . Astra Tech augments Atlantis patient-specific abutment line . . . Biomet 3i and Renishaw to collaborate on digital solutions . . . BIOLASE announces cost-cutting initiatives and organizational changes . . . DTI appoints Russell Olsen as Senior Vice President of Sales, Marketing and Service . . . Straumann's CFO steps down more
CNMD, IART, NUVA, OFIX, Synthes report 2Q:10 sales . . . Axiomed raises $14.5M . . . China Kanghui Holdings to go public . . . FDA panel votes in favor of Medtronic's Amplify . . . FDA approves Orthovita's new collagen processing facility . . . curasan seeking distribution partners for ATR . . . TranS1 launches next-gen AxiaLIF 2L+ system . . . Ortho Kinematics enrolling study more
An FDA panel voted 6-5 yesterday in favor of approving Medtronic's Amplify, a BMP-2 with a different formulation and carrier than InFuse. Heading into the meeting, concerns circulated over a higher incidence of cancer in patients treated with Amplify, though the panel ultimately voted 9-4 in support of safety (with 1 abstention) and 10-3 (with 1 abstention) on efficacy. more
Sen. Al Franken and AdvaMed faced Congress last week, urging legislators to increase financial incentives for devicemakers addressing pediatric patient populations. more
|
